Delivery of Exogenous Antigens to Induce Cytotoxic CD8+ T Lymphocyte Responses.
Vaccines intended to induce a cytotoxic CD8+ T-cell response are highly sought after. However, some of these vaccines can be problematic if they replicate in the host. An alternative strategy is to exploit cross-presentation of exogenous antigens to express peptides on major histocompatibility complex (MHC) class I molecules. During cross-presentation, the delivered exogenous antigen can be taken up and processed through diverse mechanisms. Here, we will discuss the recent advances regarding the complex nature of the cross-priming process and the models that reflect its relevance in vivo. Moreover, we summarize current data that explore potential adjuvants and vaccine vectors that deliver antigens to activate CD8+ T cells relying on cross-presentation.
Department of Microbiology and Immunology, Queen's University, Kingston, ON, Canada K7L 3N6.
Julia
J
Kim
Vandana
V
Gambhir
Attiya
A
Alatery
Sameh
S
Basta